Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Other specified types of non-Hodgkin lymphoma
- C85.8
Summary
Non-Hodgkin lymphoma (NHL) is a group of blood cancers affecting the lymphatic system. This code represents NHL types that do not fit into more specific subcategories and are explicitly documented as "other specified" in clinical records. The lymphatic system, part of the immune system, is involved in fighting infections, and NHL arises from abnormal lymphocyte growth.
Causes
The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections (e.g., Epstein-Barr virus), immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.
Risk Factors
- Advanced age (more common in older adults)
- Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
- Certain infections (e.g., hepatitis C, H. pylori)
- Exposure to chemicals (e.g., pesticides, herbicides)
- Family history of lymphoma
- Autoimmune conditions (e.g., rheumatoid arthritis)
Symptoms
- Swollen lymph nodes (neck, armpits, groin)
- Fever, night sweats, or unexplained weight loss
- Fatigue or weakness
- Abdominal pain or swelling
- Persistent cough or chest discomfort
- Itching or skin rashes
Diagnosis
Diagnosis typically involves a combination of physical examination to check for swollen lymph nodes, blood tests to assess cell counts and markers, imaging tests (e.g., CT or PET scans) to identify affected areas, and a biopsy of lymphatic tissue to confirm the presence of cancerous cells.
Treatment Options
Treatment depends on the specific type and progression of the lymphoma and may include chemotherapy, radiation therapy, immunotherapy, targeted therapy, or stem cell transplantation. The choice of treatment is guided by the patient’s overall health and the lymphoma’s characteristics.
Prognosis and Follow-Up
Prognosis varies based on the lymphoma type, stage, and patient factors. Regular follow-up appointments are essential to monitor for recurrence or treatment side effects. Long-term surveillance may involve periodic imaging or blood tests.
Complications
Potential complications include infection due to weakened immunity, organ damage from tumor growth, or side effects from treatment (e.g., fatigue, nausea, or secondary cancers).
Lifestyle & Prevention
While prevention is not always possible, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., excessive chemical exposure) may support overall health. Vaccinations and infection prevention are important for those with weakened immunity.
When to Seek Professional Help
Seek medical attention for persistent symptoms like unexplained weight loss, fever, night sweats, or swollen lymph nodes. Early evaluation is critical for timely diagnosis and treatment planning.
Tips for Medical Coders
Use C85.8 when the clinical documentation specifies "other specified types of non-Hodgkin lymphoma" and does not align with more detailed subcategories. Ensure the code is supported by clear documentation of the lymphoma type and any relevant site or histology details. Verify that the code is not used when a more specific NHL code is applicable.
C85.8 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.